What exactly did Morgan Stanley do on Feb 04, 2026 to EFX analyst rating?

On Feb 04, 2026 Morgan Stanley maintained an **Overweight** rating on EFX and removed its public price target, citing enduring EPS growth it believes the market undervalues

How should investors interpret a maintained Overweight when a price target is axed?

A maintained Overweight with no price target signals conviction in outperformance but uncertainty on fair value. Investors should focus on EPS trends and risk drivers rather than a single number

Does the EFX analyst rating change immediately affect the stock price?

Not always. Morgan Stanley’s note showed no immediate price change at release. Price moves depend on follow-up earnings, revisions, and broader market sentiment

What does Meyka AI’s B+ grade mean for EFX investors?

Meyka AI rates EFX **B+** based on benchmark comparison, sector results, financial growth, key metrics, and consensus. It is a research signal, not investment advice

Analyst Ratings

Morgan Stanley Maintains Overweight on Equifax Inc. (EFX) Feb 04, 2026

ByDanny Kontos February 5, 2026February 5, 2026

Morgan Stanley maintained an Overweight on Equifax Inc. (EFX) on Feb 04, 2026, marking a steady bullish stance even as it axed its price target. The EFX analyst rating update shows the firm sees enduring EPS growth that the market may not yet value. Morgan Stanley published the call at 03:52 PM and described long-term earnings upside as underappreciated by current multiples. Investors should note the firm kept the positive rating but removed a public price target, a rare mix of conviction and caution